seed
Stage
2
Investors
About
OneChain Immunotherapeutics is a clinical-stage spin-off from the Josep Carreras Leukemia Research Institute and ICREA developing CAR-T cell therapies for oncological diseases.
Explore OneChain Immunotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.